Rating Change
Wedbush reiterated its Outperform rating on Immunome, Inc. (NASDAQ:IMNM) on August 12, 2026.
reiterateNASDAQ:IMNM
Wedbush Reiterates Outperform Rating on Immunome, Inc. (IMNM)
Wedbush reiterated its Outperform rating on Immunome, Inc. (NASDAQ:IMNM) on August 12, 2026.
At publication ·
What changed
Immunome, Inc. (NASDAQ:IMNM) · reiterate
- Firm
- Wedbush
- Rating
- Outperform to Outperform
- Price at event
- $27.99
- Market capitalization
- $1.8B
At a glance
Key takeaways
- Wedbush reiterated an Outperform rating on Immunome, Inc. (IMNM) on August 12, 2026, with the stock trading at $27.99 and a market capitalization of $1.8 billion.
Market Context
Immunome, Inc. operates in the Healthcare sector. The stock currently trades at $27.99 with a market capitalization of $1.8B.
Analyst coverage from Wedbush provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Immunome, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Immunome, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 12, 2026 | Wedbush | Outperform | N/A |
| Aug 12, 2026 | Truist Securities | Buy | N/A |
| Jul 21, 2026 | Wedbush | Outperform | N/A |
| Jun 12, 2026 | Wedbush | Outperform | N/A |
| May 28, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View IMNM Stock Page
Frequently Asked Questions
What does the Outperform rating mean for IMNM?
A rating of Outperform from Wedbush reflects the analyst's outlook on Immunome, Inc. (NASDAQ:IMNM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IMNM forecast page.